The findings of a new study reveal a microbe-immune axis that is disrupted in pregnant animals, suggesting potential therapeutic approaches for pregnancy-associated sepsis.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, spoke about how the research in gut-brain axes could pave the way to new microbiome based therapies in neurodegenerative diseases.
Industry
Sponsored by
Bio-Me launching an extensive qPCR solution for skin microbiome analysis.
Specific gut bacteria and/or metabolites could be responsible for the differential responses to weight management.
The findings of a new study suggest that a newborn’s lung immunity is influenced by the interplay between maternal γδ T cells, the gut microbiota and microbial-derived SCFAs.
Oliver Worsley: ‘The collaboration will give us the opportunity to further understand how molecular changes on the skin may translate to skin and human health’.
Tim Sharpington, Chief Executive Officer at Microbiotica, talked about how the microbiome field should navigate through a difficult financing horizon.
New study shows that specific probiotics significantly contribute to the modulation of mood and sleep quality during stressful periods.
The results of the study showed that exposure to metal oxide nanoparticles led to changes in the microbial populations
The findings of a new study suggest that mycobiome maturation and infant growth trajectories are linked.
